armodafinil 150 mg

DRUG2 trials

Sponsors

Cephalon, Alliance for Clinical Trials in Oncology

Conditions

Chronic Shift Work Sleep DisorderFatigue

Phase 3

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

CompletedNCT00236080

CephalonChronic Shift Work Sleep Disorder

Start: 2005-08-31End: 2005-12-31Updated: 2013-07-19

Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

CompletedNCT01781468

Alliance for Clinical Trials in OncologyFatigue

Start: 2013-06-21End: 2019-12-15Updated: 2025-01-27

Related Papers

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma

JAMA Oncology2021-12-0934 citations

A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue in patients with high-grade glioma (Alliance A221101).

Journal of Clinical Oncology2020-05-203 citations

Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology

Neuro-Oncology Practice2018-11-244 citations